소개

이 페이지에서는 Henderson Lori M.의 공개된 내부자의 매매 거래 내역을 종합적으로 분석합니다. 내부자들은 기업의 임원(내부 경영진), 이사 또는 주요 투자자입니다. 일반적으로 내부자가 중요한 비공개 정보를 기반으로 자신이 속한 기업을 거래하는 것은 불법으로 간주됩니다. 이것은 내부자가 자신의 기업 내에서 행하는 모든 거래가 불법이라는 것을 뜻은 아닙니다. 그러나 그들은 자신들의 모든 거래를 양식 4를 통해 SEC에 보고해야만 합니다. 이러한 제한에도 불구하고, 학계 연구에 따르면 내부자는, 일반적으로, 자신의 회사 주식에 대한 실적이 시장의 수익률을 능가하는 경향성을 보였습니다.

평균 거래 수익성

평균 거래 수익성은 내부자가 지난 3년 동안 매입한 모든 "공개 시장"(Open market)에서의 매입의 평균 수익률입니다. 이를 계산하기 위해 10b5-1 거래 계획의 일부로 표시된 모든 거래를 제외하고 내부자가 계획되지 않은 모든 오픈 마켓에서의 매입을 조사합니다. 그런 다음 3개월, 6개월, 12개월 동안 해당 거래의 평균 성과를 계산하여 각 거래에 대한 최종 성과 지표를 생성합니다. 마지막으로 내부자에 대한 성과 지표를 계산하기 위해 모든 성과 지표의 평균을 내립니다. 이 목록에는 지난 2년 동안 최소 3번 이상 거래한 내부자만 포함됩니다.

내부자의 매매 거래 수익성이 "해당 없음"인 경우, 내부자는 지난 3년 동안 공개 시장에서 매수한 적이 없거나, 거래가 너무 최근에 이루어져서 신뢰할 수 있는 성과 지표를 산출할 수 없는 경우에 해당합니다.

업데이트 주기: 일별

최고 수익율의 내부자 목록을 확인하세요.

내부자 포지션이 보고된 기업

SEC 서류에 따르면 Henderson Lori M. 기업이 다음 기업에 대한 보유 또는 거래를 보고했습니다:

증권 소유권 최근 보고된 보유 주식
US:MRNA / Moderna, Inc. General Counsel and Secretary 328,352
US:AMRI / Albany Molecular Research, Inc. SVP, Secretary & Gen Counsel 0
차트 해석 방법

아래 차트는 Henderson Lori M.에 의한 각 "공개 시장"(Open market)에서 계획되지 않은 거래 이후 증권의 주가 실적을 보여줍니다. 계획되지 않은 거래는 10b5-1 거래 계획의 일환으로 이루어지지 않은 거래입니다. 주가 실적은 주가의 누적 백분율 변화로 표시됩니다. 예를 들어, 2019년 1월 1일 내부자의 매매 거래가 이루어졌을 경우, 차트는 현재까지 증권의 일별 백분율 변화를 보여줍니다. 이 기간 동안 주가가 10달러에서 15달러로 간다면, 주가의 누적 백분율 변화는 50%가 됩니다. 10달러에서 20달러로의 가격 변화는 100%가 되며, 10달러에서 5달러로의 가격 변화는 -50%가 됩니다.

궁극적으로 내부자의 매매 거래가 내부자의 정보를 이용하여 이익을 얻기 위해 거래 타이밍을 맞추고 있는지 확인하기 위해 내부자의 매매 거래가 주가의 초과 수익률(양 또는 음)과 얼마나 밀접한 상관 관계가 있는지 확인하고자 합니다. 내부자가 이러한 작업을 수행하고 있는 상황을 고려해 보겠습니다. 이러한 상황에서 우리는 (a) 매입 후 양의 수익률 또는 (b) 매각 후 음의 수익률을 기대할 수 있습니다. (a)의 경우, 매입 차트는 상향으로 기울어진 일련의 곡선을 보여주며, 각 매입 거래 후 양의 수익률을 나타냅니다. (b)의 경우, SALE 차트는 하향으로 기울어진 일련의 곡선을 보여주며, 각 판매 거래 후 음의 수익률을 나타냅니다.

그러나 이것만으로는 결론을 도출하기에 충분하지 않습니다. 예를 들어, 해당 기업의 주가가 수년에 걸쳐 비주기적 상승 추세에 있다면, Fintel은 매입 후 도표가 모두 상향 곡선으로 예상할 수 있습니다. 마찬가지로, 수년에 걸쳐 비주기적 하락은 거래 후에 하향 곡선으로 초래할 가능성이 높습니다. 이 도표들 중 어느 것도 내부자의 매매 거래 활동을 시사하지는 않습니다.

가장 강력한 지표는 주가가 극단적으로 순환하는 상황일 것이고, PURCHASE 차트에는 긍정적인 시그널이, SALE 차트에는 부정적인 플롯이 존재했습니다. 이는 자신들의 금전적 이익을 위한 거래 타이밍을 재던 내부자에 의한 상황일 가능성이 높습니다.

내부자의 매매 거래 내역

아래 표는 증권거래위원회(SEC)에 공시된 Henderson Lori M.의 내부자의 전체 거래 목록입니다.

보고일 거래일 보고 티커 증권 코드 10b5-1 지분 잔여 지분 변동률
(%)
지분
가치
거래
가치
잔여
가치
2021-05-28 2021-05-27 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,600 328,352 -1.97
2021-05-28 2021-05-27 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 174.20 -1,149,720 156,954
2021-05-28 2021-05-27 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,600 7,501 732.52 14.85 98,010 111,390
2021-05-27 2021-05-25 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,600 334,952 -1.93
2021-05-27 2021-05-25 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 166.58 -1,099,428 150,089
2021-05-27 2021-05-25 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,600 7,501 732.52 14.85 98,010 111,390
2021-05-21 2021-05-20 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,600 341,552 -1.90
2021-05-21 2021-05-20 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 159.92 -1,055,472 144,088
2021-05-21 2021-05-20 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,600 7,501 732.52 14.85 98,010 111,390
2021-05-20 2021-05-18 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,600 348,152 -1.86
2021-05-20 2021-05-18 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 160.16 -1,057,056 144,304
2021-05-20 2021-05-18 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,600 7,501 732.52 14.85 98,010 111,390
2021-05-14 2021-05-13 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,600 354,752 -1.83
2021-05-14 2021-05-13 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 152.60 -1,007,160 137,493
2021-05-14 2021-05-13 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,600 7,501 732.52 14.85 98,010 111,390
2021-05-13 2021-05-11 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,170 361,352 -1.68
2021-05-13 2021-05-11 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -430 93,046 -0.46
2021-05-13 2021-05-11 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 151.31 -998,646 136,330
2021-05-13 2021-05-11 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,170 7,501 463.56 14.85 91,624 111,390
2021-05-13 2021-05-11 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 430 1,331 47.72 20.93 9,000 27,858
2021-05-07 2021-05-06 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,600 93,476 -6.59
2021-05-07 2021-05-06 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 147.82 -975,612 133,186
2021-05-07 2021-05-06 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,600 7,501 732.52 20.93 138,138 156,996
2021-05-06 2021-05-04 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,600 100,076 -6.19
2021-05-06 2021-05-04 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 185.25 -1,222,650 166,910
2021-05-06 2021-05-04 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,600 7,501 732.52 20.93 138,138 156,996
2021-04-30 2021-04-29 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,600 106,676 -5.83
2021-04-30 2021-04-29 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 182.49 -1,204,434 164,423
2021-04-30 2021-04-29 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,600 7,501 732.52 20.93 138,138 156,996
2021-04-29 2021-04-27 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,600 113,276 -5.51
2021-04-29 2021-04-27 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 178.29 -1,176,714 160,639
2021-04-29 2021-04-27 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,600 7,501 732.52 20.93 138,138 156,996
2021-04-23 2021-04-22 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,600 119,876 -5.22
2021-04-23 2021-04-22 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 168.26 -1,110,516 151,602
2021-04-23 2021-04-22 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,600 7,501 732.52 20.93 138,138 156,996
2021-04-22 2021-04-20 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,600 126,476 -4.96
2021-04-22 2021-04-20 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 160.32 -1,058,112 144,448
2021-04-22 2021-04-20 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,600 7,501 732.52 20.93 138,138 156,996
2021-04-16 2021-04-15 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,600 133,076 -4.73
2021-04-16 2021-04-15 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 158.76 -1,047,816 143,043
2021-04-16 2021-04-15 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,600 7,501 732.52 20.93 138,138 156,996
2021-04-14 2021-04-13 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,600 139,676 -4.51
2021-04-14 2021-04-13 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 146.62 -967,692 132,105
2021-04-14 2021-04-13 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,600 7,501 732.52 20.93 138,138 156,996
2021-04-09 2021-04-08 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,600 146,276 -4.32
2021-04-09 2021-04-08 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 132.85 -876,810 119,698
2021-04-09 2021-04-08 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,600 7,501 732.52 20.93 138,138 156,996
2021-04-08 2021-04-06 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,600 152,876 -4.14
2021-04-08 2021-04-06 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 130.01 -858,066 117,139
2021-04-08 2021-04-06 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,600 7,501 732.52 20.93 138,138 156,996
2021-04-02 2021-04-01 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,600 159,476 -3.97
2021-04-02 2021-04-01 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 132.51 -874,566 119,392
2021-04-02 2021-04-01 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,600 7,501 732.52 20.93 138,138 156,996
2021-04-01 2021-03-30 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,600 166,076 -3.82
2021-04-01 2021-03-30 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 123.30 -813,780 111,093
2021-04-01 2021-03-30 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,600 7,501 732.52 20.93 138,138 156,996
2021-03-26 2021-03-25 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,600 172,676 -3.68
2021-03-26 2021-03-25 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 126.88 -837,408 114,319
2021-03-26 2021-03-25 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,600 7,501 732.52 20.93 138,138 156,996
2021-03-25 2021-03-23 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,600 179,276 -3.55
2021-03-25 2021-03-23 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 145.55 -960,630 131,141
2021-03-25 2021-03-23 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,600 7,501 732.52 20.93 138,138 156,996
2021-03-19 2021-03-18 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -216 185,876 -0.12
2021-03-19 2021-03-18 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,384 118,155 -5.13
2021-03-19 2021-03-18 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 144.39 -952,974 130,095
2021-03-19 2021-03-18 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 216 7,501 2.96 20.93 4,521 156,996
2021-03-19 2021-03-18 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,384 7,285 708.55 25.93 165,537 188,900
2021-03-18 2021-03-16 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,600 124,539 -5.03
2021-03-18 2021-03-16 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 148.50 -980,100 133,798
2021-03-18 2021-03-16 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,600 7,501 732.52 25.93 171,138 194,501
2021-03-12 2021-03-11 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,600 131,139 -4.79
2021-03-12 2021-03-11 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 133.29 -879,714 120,094
2021-03-12 2021-03-11 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,600 7,501 732.52 25.93 171,138 194,501
2021-03-10 2021-03-09 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,600 137,739 -4.57
2021-03-10 2021-03-09 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 127.11 -838,926 114,526
2021-03-10 2021-03-09 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,600 7,501 732.52 25.93 171,138 194,501
2021-03-05 2021-03-04 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,600 144,339 -4.37
2021-03-05 2021-03-04 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 128.58 -848,628 115,851
2021-03-05 2021-03-04 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,600 7,501 732.52 25.93 171,138 194,501
2021-03-04 2021-03-02 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,600 150,939 -4.19
2021-03-04 2021-03-02 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 153.77 -1,014,882 138,547
2021-03-04 2021-03-02 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,600 7,501 732.52 25.93 171,138 194,501
2020-10-23 2020-10-21 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -32,000 367,522 -8.01
2020-10-23 2020-10-21 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -700 681 -50.69 71.39 -49,973 48,617
2020-10-23 2020-10-21 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -15,455 1,381 -91.80 70.56 -1,090,505 97,443
2020-10-23 2020-10-21 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -14,148 16,836 -45.66 69.84 -988,096 1,175,826
2020-10-23 2020-10-21 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -1,697 30,984 -5.19 68.70 -116,584 2,128,601
2020-10-23 2020-10-21 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 32,000 32,681 4,698.97 14.85 475,200 485,313
2020-06-19 2020-06-18 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -64,000 399,522 -13.81
2020-06-19 2020-06-18 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -64,000 681 -98.95 63.03 -4,033,920 42,923
2020-06-19 2020-06-18 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 64,000 64,681 9,397.94 14.85 950,400 960,513
2020-06-04 2020-05-20 4/A MRNA Moderna, Inc.
Common Stock
S - Sale X -64,000 0 -100.00 70.00 -4,480,000
2020-05-22 2020-05-20 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -64,000 463,522 -12.13
2020-05-22 2020-05-20 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -64,000 0 -100.00 70.00 -4,480,000
2020-05-22 2020-05-20 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 64,000 64,000 14.85 950,400 950,400
2020-03-03 2020-02-28 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
A - Award 157,539 157,539
2019-03-11 2019-03-08 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
A - Award 186,092 186,092
2017-09-05 2017-08-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock
D - Sale to Issuer -44,251 0 -100.00 3.34 -147,798
2017-09-05 2017-08-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock
D - Sale to Issuer -29,066 0 -100.00 5.98 -173,815
2017-09-05 2017-08-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock
D - Sale to Issuer -22,893 0 -100.00 4.70 -107,597
2017-09-05 2017-08-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock
D - Sale to Issuer -29,167 0 -100.00 11.32 -330,170
2017-09-05 2017-08-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock
D - Sale to Issuer -4,375 0 -100.00 15.76 -68,950
2017-09-05 2017-08-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock
D - Sale to Issuer -4,375 0 -100.00 15.76 -68,950
2017-09-05 2017-08-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock
D - Sale to Issuer -4,375 0 -100.00 15.76 -68,950
2017-09-05 2017-08-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock
D - Sale to Issuer -17,500 0 -100.00 15.76 -275,800
2017-09-05 2017-08-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock
D - Sale to Issuer -17,500 0 -100.00 18.82 -329,350
2017-09-05 2017-08-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock
D - Sale to Issuer -4,375 0 -100.00 18.82 -82,338
2017-09-05 2017-08-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock
D - Sale to Issuer -4,375 0 -100.00 18.82 -82,338
2017-09-05 2017-08-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock
D - Sale to Issuer -17,500 0 -100.00 16.50 -288,750
2017-09-05 2017-08-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock
D - Sale to Issuer -50,000 0 -100.00 16.88 -844,000
2017-09-05 2017-08-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
D - Sale to Issuer -66,717 0 -100.00 21.75 -1,451,095
2017-09-05 2017-08-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
A - Award 4,722 66,717 7.62
2017-09-05 2017-08-28 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
G - Gift -9,857 52,138 -15.90
2017-03-06 2017-03-02 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
F - Taxes -432 61,995 -0.69 14.52 -6,273 900,167
2017-02-10 2017-02-08 4 AMRI ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock
A - Award 44,251 44,251
2017-02-10 2017-02-08 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
A - Award 6,747 62,427 12.12
2017-02-10 2017-02-08 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
A - Award 8,990 55,680 19.25
2017-02-07 2017-02-04 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
F - Taxes -504 46,690 -1.07 18.52 -9,334 864,699
2017-02-07 2017-02-04 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
F - Taxes -674 47,194 -1.41 18.52 -12,482 874,033
2017-02-07 2017-02-04 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
F - Taxes -2,363 47,868 -4.70 18.52 -43,763 886,515
2017-02-01 2017-01-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
F - Taxes -553 50,231 -1.09 18.11 -10,015 909,683
2017-02-01 2017-01-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
F - Taxes -553 50,231 -1.09 18.11 -10,015 909,683
2016-11-17 2016-11-16 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
S - Sale -6,000 51,337 -10.46 17.00 -102,000 872,729
2016-11-03 2016-11-02 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
F - Taxes -409 57,337 -0.71 15.09 -6,172 865,215
2016-03-04 2016-03-02 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
F - Taxes -421 57,746 -0.72 15.33 -6,454 885,246
2016-02-19 2016-02-17 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
D - Sale to Issuer -1,459 58,167 -2.45
2016-02-19 2016-02-17 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
F - Taxes -463 59,626 -0.77 15.37 -7,116 916,452
2016-02-08 2016-02-04 4 AMRI ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock
A - Award 29,066 29,066 15.77 458,371 458,371
2016-02-08 2016-02-04 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
A - Award 12,682 60,089 26.75 15.77 199,995 947,604
2016-02-05 2016-02-04 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
F - Taxes -684 47,407 -1.42 16.16 -11,053 766,097
2016-02-01 2016-01-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
F - Taxes -554 48,091 -1.14 15.97 -8,847 768,013
2016-02-01 2016-01-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
F - Taxes -554 48,091 -1.14 15.97 -8,847 768,013
2015-11-04 2015-11-02 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
A - Award 5,000 49,199 11.31 19.16 95,800 942,653
2015-06-04 2015-06-02 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
D - Sale to Issuer -1,459 44,199 -3.20
2015-06-04 2015-06-02 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
F - Taxes -476 45,658 -1.03
2015-03-04 2015-03-02 4 AMRI ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock
A - Award 22,893 22,893 17.05 390,326 390,326
2015-03-04 2015-03-02 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
A - Award 10,588 46,134 29.79 17.05 180,525 786,585
2015-02-19 2015-02-17 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
D - Sale to Issuer -1,458 35,546 -3.94
2015-02-19 2015-02-17 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
F - Taxes -464 37,004 -1.24
2015-02-06 2015-02-04 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
F - Taxes -1,582 37,468 -4.05
2015-02-03 2015-01-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
D - Sale to Issuer -1,459 39,050 -3.60
2015-02-03 2015-01-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
F - Taxes -554 40,509 -1.35
2014-10-01 2014-10-01 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
S - Sale X -1,000 41,063 -2.38 21.48 -21,480 882,033
2014-09-03 2014-09-02 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
S - Sale X -2,500 42,063 -5.61 19.56 -48,900 822,752
2014-08-13 2014-08-12 4 AMRI ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock
M - Exercise 30,000 50,000 150.00 4.87 146,100 243,500
2014-08-13 2014-08-12 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
S - Sale -30,000 44,563 -40.23 19.05 -571,500 848,925
2014-08-13 2014-08-12 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
M - Exercise 30,000 74,563 67.32 4.87 146,100 363,122
2014-08-01 2014-08-01 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
S - Sale X -2,500 44,563 -5.31 18.56 -46,400 827,089
2014-07-02 2014-07-01 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
S - Sale X -2,500 47,063 -5.04 20.62 -51,550 970,439
2014-06-04 2014-06-02 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
F - Taxes -476 49,563 -0.95
2014-06-04 2014-06-02 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
D - Sale to Issuer -1,458 50,039 -2.83
2014-06-04 2014-06-02 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
S - Sale X -2,500 51,497 -4.63 16.32 -40,800 840,431
2014-05-01 2014-05-01 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
S - Sale X -2,500 53,997 -4.43 15.73 -39,325 849,373
2014-04-02 2014-04-01 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
S - Sale X -2,500 56,497 -4.24 18.74 -46,850 1,058,754
2014-02-19 2014-02-17 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
F - Taxes -1,038 58,997 -1.73
2014-02-06 2014-02-04 4 AMRI ALBANY MOLECULAR RESEARCH INC
Option to purchase Common Stock
A - Award 29,167 29,167 10.43 304,212 304,212
2014-02-06 2014-02-04 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
A - Award 14,584 60,035 32.09 10.43 152,111 626,165
2014-02-06 2014-02-04 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
F - Taxes -948 45,451 -2.04
2014-02-04 2014-01-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
F - Taxes -1,106 46,399 -2.33
2013-06-04 2013-06-02 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
F - Taxes -477 47,505 -0.99
2013-06-04 2013-06-02 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
D - Sale to Issuer -1,458 47,982 -2.95
2013-02-04 2013-01-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Option to purchase Common Stock
A - Award 35,000 35,000 5.99 209,650 209,650
2013-02-04 2013-01-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
A - Award 11,666 49,440 30.88 5.99 69,879 296,146
2012-06-12 2012-06-02 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
D - Sale to Issuer -1,458 37,774 -3.72
2012-02-21 2012-02-17 4 AMRI ALBANY MOLECULAR RESEARCH INC
Option to purchase Common Stock
A - Award 35,000 35,000 2.93 102,550 102,550
2012-02-21 2012-02-17 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
A - Award 11,666 39,232 42.32 2.93 34,181 114,950
P
공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매입
S
공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매각
A
자사로부터 유가증권(옵션 등)을 보조, 지급 또는 기타 취득
C
파생상품 전환
D
자사에게 유가증권을 매각 또는 양도
F
기업으로부터 인도 받은 유가증권의 일부를 사용한 행사 가격 또는 조세 채무의 지급
G
내부자에 의한 또는 내부자에게 증권 증여
K
지분스왑 및 유사 위험 회피거래
M
자사로부터 인도 받은 파생증권(옵션 등)의 행사 또는 전환
V
보고서 양식 4에 자진 신고된 거래
J
기타 (거래 내용을 설명하는 각주와 동반)